Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study

Background This study was designed to identify the optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma (LPS) is suspected. Methods Patients who underwent salvage operation at Samsung Medical Center for recurrent retroperitoneal LPS from January 2000...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2019-05, Vol.24 (5), p.583-589
Hauptverfasser: Rhu, Jinsoo, Cho, Chan Woo, Lee, Kyo Won, Park, Jae Berm, Kim, Sung Joo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 589
container_issue 5
container_start_page 583
container_title International journal of clinical oncology
container_volume 24
creator Rhu, Jinsoo
Cho, Chan Woo
Lee, Kyo Won
Park, Jae Berm
Kim, Sung Joo
description Background This study was designed to identify the optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma (LPS) is suspected. Methods Patients who underwent salvage operation at Samsung Medical Center for recurrent retroperitoneal LPS from January 2000 to December 2015 were reviewed. The time interval between recurrence and operation for recurrence was divided by 1, 2 or 3 months. A Cox proportional-hazards model was used to analyze factors related to disease-free survival along with recurrence-to-operation interval divided by 1, 2 or 3 months. Results The 1-, 3-, and 5-year disease-free survival rates were 43.2%, 15.6% and 13.4%, respectively. FNCLCC grade ( p  = 0.023) and recurrence-to-operation interval divided by 3 months ( p  = 0.003) were significant factors associated with recurrence. FNCLCC grade 2 (HR 1.940, CI 0.935–4.026, p  = 0.238) and grade 3 (HR 4.049, CI 1.767–9.281, p  = 0.007) showed increased risk compared to grade 1. Patients who underwent salvage operation more than 3 months after recurrence showed significantly increased risk of recurrence compared to patients within 3 months (HR 2.724, CI 1.391–5.337, p  = 0.003). Conclusions Based on our analysis of recurrence-free survival, salvage operation can be delayed for less than 3 months when recurrence is suspected. A short-term follow-up imaging study should be performed within this period.
doi_str_mv 10.1007/s10147-018-01383-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2163008770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2163008770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-95ca0520787f4ed7925a5a471d2205eec068497db6b9c87e1efb837225b749233</originalsourceid><addsrcrecordid>eNp9kcuO1DAQRS0EYoaBH2CBLLFhE_AzlbBDI17SSLOBteU4lSajxA5-0PQv8NW46QYkFiyssnVP3bLqEvKUs5ecMXiVOOMKGsa7emQnm_09csmVhAYAxP16l4o3fSv0BXmU0h1jHFotHpILyVqmeCsuyY_bLc-rXehqv89rWelYos1z8HQKkY642MPsdzTZ5ZvdIQ0bnuX9F_Q0oisxondVmeorxyMw5-CxWi7zFpKNLqyWzommkjZ0GcfX1NJUXRdsHPqMkaZcxsNj8mCyS8In53pFPr97--n6Q3Nz-_7j9Zubxsm-z02vnWVaMOhgUjhCL7TVVgEfhWAa0bG2Uz2MQzv0rgPkOA2dBCH0AKoXUl6RFyffLYavBVM265wcLov1GEoygreSsQ6AVfT5P-hdKNHX3x0p0YJQGiolTpSLIaWIk9li3Wk8GM7MMSlzSsrUpMyvpMy-Nj07W5dhxfFPy-9oKiBPQKqS32H8O_s_tj8BMH-hTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2162672457</pqid></control><display><type>article</type><title>Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study</title><source>SpringerLink Journals - AutoHoldings</source><creator>Rhu, Jinsoo ; Cho, Chan Woo ; Lee, Kyo Won ; Park, Jae Berm ; Kim, Sung Joo</creator><creatorcontrib>Rhu, Jinsoo ; Cho, Chan Woo ; Lee, Kyo Won ; Park, Jae Berm ; Kim, Sung Joo</creatorcontrib><description>Background This study was designed to identify the optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma (LPS) is suspected. Methods Patients who underwent salvage operation at Samsung Medical Center for recurrent retroperitoneal LPS from January 2000 to December 2015 were reviewed. The time interval between recurrence and operation for recurrence was divided by 1, 2 or 3 months. A Cox proportional-hazards model was used to analyze factors related to disease-free survival along with recurrence-to-operation interval divided by 1, 2 or 3 months. Results The 1-, 3-, and 5-year disease-free survival rates were 43.2%, 15.6% and 13.4%, respectively. FNCLCC grade ( p  = 0.023) and recurrence-to-operation interval divided by 3 months ( p  = 0.003) were significant factors associated with recurrence. FNCLCC grade 2 (HR 1.940, CI 0.935–4.026, p  = 0.238) and grade 3 (HR 4.049, CI 1.767–9.281, p  = 0.007) showed increased risk compared to grade 1. Patients who underwent salvage operation more than 3 months after recurrence showed significantly increased risk of recurrence compared to patients within 3 months (HR 2.724, CI 1.391–5.337, p  = 0.003). Conclusions Based on our analysis of recurrence-free survival, salvage operation can be delayed for less than 3 months when recurrence is suspected. A short-term follow-up imaging study should be performed within this period.</description><identifier>ISSN: 1341-9625</identifier><identifier>EISSN: 1437-7772</identifier><identifier>DOI: 10.1007/s10147-018-01383-w</identifier><identifier>PMID: 30604162</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Cancer Research ; Gastric cancer ; Liposarcoma ; Medicine ; Medicine &amp; Public Health ; Oncology ; Original Article ; Salvage ; Sarcoma ; Surgical Oncology ; Survival</subject><ispartof>International journal of clinical oncology, 2019-05, Vol.24 (5), p.583-589</ispartof><rights>Japan Society of Clinical Oncology 2019</rights><rights>International Journal of Clinical Oncology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-95ca0520787f4ed7925a5a471d2205eec068497db6b9c87e1efb837225b749233</citedby><cites>FETCH-LOGICAL-c399t-95ca0520787f4ed7925a5a471d2205eec068497db6b9c87e1efb837225b749233</cites><orcidid>0000-0001-9809-8525</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10147-018-01383-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10147-018-01383-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30604162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rhu, Jinsoo</creatorcontrib><creatorcontrib>Cho, Chan Woo</creatorcontrib><creatorcontrib>Lee, Kyo Won</creatorcontrib><creatorcontrib>Park, Jae Berm</creatorcontrib><creatorcontrib>Kim, Sung Joo</creatorcontrib><title>Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study</title><title>International journal of clinical oncology</title><addtitle>Int J Clin Oncol</addtitle><addtitle>Int J Clin Oncol</addtitle><description>Background This study was designed to identify the optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma (LPS) is suspected. Methods Patients who underwent salvage operation at Samsung Medical Center for recurrent retroperitoneal LPS from January 2000 to December 2015 were reviewed. The time interval between recurrence and operation for recurrence was divided by 1, 2 or 3 months. A Cox proportional-hazards model was used to analyze factors related to disease-free survival along with recurrence-to-operation interval divided by 1, 2 or 3 months. Results The 1-, 3-, and 5-year disease-free survival rates were 43.2%, 15.6% and 13.4%, respectively. FNCLCC grade ( p  = 0.023) and recurrence-to-operation interval divided by 3 months ( p  = 0.003) were significant factors associated with recurrence. FNCLCC grade 2 (HR 1.940, CI 0.935–4.026, p  = 0.238) and grade 3 (HR 4.049, CI 1.767–9.281, p  = 0.007) showed increased risk compared to grade 1. Patients who underwent salvage operation more than 3 months after recurrence showed significantly increased risk of recurrence compared to patients within 3 months (HR 2.724, CI 1.391–5.337, p  = 0.003). Conclusions Based on our analysis of recurrence-free survival, salvage operation can be delayed for less than 3 months when recurrence is suspected. A short-term follow-up imaging study should be performed within this period.</description><subject>Cancer Research</subject><subject>Gastric cancer</subject><subject>Liposarcoma</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Salvage</subject><subject>Sarcoma</subject><subject>Surgical Oncology</subject><subject>Survival</subject><issn>1341-9625</issn><issn>1437-7772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kcuO1DAQRS0EYoaBH2CBLLFhE_AzlbBDI17SSLOBteU4lSajxA5-0PQv8NW46QYkFiyssnVP3bLqEvKUs5ecMXiVOOMKGsa7emQnm_09csmVhAYAxP16l4o3fSv0BXmU0h1jHFotHpILyVqmeCsuyY_bLc-rXehqv89rWelYos1z8HQKkY642MPsdzTZ5ZvdIQ0bnuX9F_Q0oisxondVmeorxyMw5-CxWi7zFpKNLqyWzommkjZ0GcfX1NJUXRdsHPqMkaZcxsNj8mCyS8In53pFPr97--n6Q3Nz-_7j9Zubxsm-z02vnWVaMOhgUjhCL7TVVgEfhWAa0bG2Uz2MQzv0rgPkOA2dBCH0AKoXUl6RFyffLYavBVM265wcLov1GEoygreSsQ6AVfT5P-hdKNHX3x0p0YJQGiolTpSLIaWIk9li3Wk8GM7MMSlzSsrUpMyvpMy-Nj07W5dhxfFPy-9oKiBPQKqS32H8O_s_tj8BMH-hTA</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Rhu, Jinsoo</creator><creator>Cho, Chan Woo</creator><creator>Lee, Kyo Won</creator><creator>Park, Jae Berm</creator><creator>Kim, Sung Joo</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9809-8525</orcidid></search><sort><creationdate>20190501</creationdate><title>Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study</title><author>Rhu, Jinsoo ; Cho, Chan Woo ; Lee, Kyo Won ; Park, Jae Berm ; Kim, Sung Joo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-95ca0520787f4ed7925a5a471d2205eec068497db6b9c87e1efb837225b749233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cancer Research</topic><topic>Gastric cancer</topic><topic>Liposarcoma</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Salvage</topic><topic>Sarcoma</topic><topic>Surgical Oncology</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rhu, Jinsoo</creatorcontrib><creatorcontrib>Cho, Chan Woo</creatorcontrib><creatorcontrib>Lee, Kyo Won</creatorcontrib><creatorcontrib>Park, Jae Berm</creatorcontrib><creatorcontrib>Kim, Sung Joo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rhu, Jinsoo</au><au>Cho, Chan Woo</au><au>Lee, Kyo Won</au><au>Park, Jae Berm</au><au>Kim, Sung Joo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study</atitle><jtitle>International journal of clinical oncology</jtitle><stitle>Int J Clin Oncol</stitle><addtitle>Int J Clin Oncol</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>24</volume><issue>5</issue><spage>583</spage><epage>589</epage><pages>583-589</pages><issn>1341-9625</issn><eissn>1437-7772</eissn><abstract>Background This study was designed to identify the optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma (LPS) is suspected. Methods Patients who underwent salvage operation at Samsung Medical Center for recurrent retroperitoneal LPS from January 2000 to December 2015 were reviewed. The time interval between recurrence and operation for recurrence was divided by 1, 2 or 3 months. A Cox proportional-hazards model was used to analyze factors related to disease-free survival along with recurrence-to-operation interval divided by 1, 2 or 3 months. Results The 1-, 3-, and 5-year disease-free survival rates were 43.2%, 15.6% and 13.4%, respectively. FNCLCC grade ( p  = 0.023) and recurrence-to-operation interval divided by 3 months ( p  = 0.003) were significant factors associated with recurrence. FNCLCC grade 2 (HR 1.940, CI 0.935–4.026, p  = 0.238) and grade 3 (HR 4.049, CI 1.767–9.281, p  = 0.007) showed increased risk compared to grade 1. Patients who underwent salvage operation more than 3 months after recurrence showed significantly increased risk of recurrence compared to patients within 3 months (HR 2.724, CI 1.391–5.337, p  = 0.003). Conclusions Based on our analysis of recurrence-free survival, salvage operation can be delayed for less than 3 months when recurrence is suspected. A short-term follow-up imaging study should be performed within this period.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>30604162</pmid><doi>10.1007/s10147-018-01383-w</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9809-8525</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1341-9625
ispartof International journal of clinical oncology, 2019-05, Vol.24 (5), p.583-589
issn 1341-9625
1437-7772
language eng
recordid cdi_proquest_miscellaneous_2163008770
source SpringerLink Journals - AutoHoldings
subjects Cancer Research
Gastric cancer
Liposarcoma
Medicine
Medicine & Public Health
Oncology
Original Article
Salvage
Sarcoma
Surgical Oncology
Survival
title Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A44%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimal%20maximum%20duration%20for%20delaying%20salvage%20operation%20when%20recurrence%20of%20retroperitoneal%20liposarcoma%20is%20suspected:%20a%20single-center%20study&rft.jtitle=International%20journal%20of%20clinical%20oncology&rft.au=Rhu,%20Jinsoo&rft.date=2019-05-01&rft.volume=24&rft.issue=5&rft.spage=583&rft.epage=589&rft.pages=583-589&rft.issn=1341-9625&rft.eissn=1437-7772&rft_id=info:doi/10.1007/s10147-018-01383-w&rft_dat=%3Cproquest_cross%3E2163008770%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2162672457&rft_id=info:pmid/30604162&rfr_iscdi=true